HC Wainwright & Co. Reiterates Buy on Aura Biosciences, Maintains $22 Price Target
3/30/2026
Impact: 70
Healthcare
HC Wainwright & Co. analyst Andres Y. Maldonado has reiterated a Buy rating on Aura Biosciences (NASDAQ: AURA) and maintained a price target of $22 for the company's stock.
AI summary, not financial advice
Share: